CN106109798A - 用于接骨和治疗跌打损伤、骨质增生的膏药及其制备方法 - Google Patents
用于接骨和治疗跌打损伤、骨质增生的膏药及其制备方法 Download PDFInfo
- Publication number
- CN106109798A CN106109798A CN201610603729.7A CN201610603729A CN106109798A CN 106109798 A CN106109798 A CN 106109798A CN 201610603729 A CN201610603729 A CN 201610603729A CN 106109798 A CN106109798 A CN 106109798A
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- hyperosteogeny
- plaster
- traumatic injury
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000014674 injury Diseases 0.000 title claims abstract description 54
- 230000008736 traumatic injury Effects 0.000 title claims abstract description 50
- 239000011505 plaster Substances 0.000 title claims abstract description 44
- 206010005963 Bone formation increased Diseases 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 238000011282 treatment Methods 0.000 claims abstract description 44
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 27
- 244000293323 Cosmos caudatus Species 0.000 claims abstract description 22
- 235000005956 Cosmos caudatus Nutrition 0.000 claims abstract description 22
- 241001057584 Myrrha Species 0.000 claims abstract description 22
- 241000717739 Boswellia sacra Species 0.000 claims abstract description 21
- 239000004863 Frankincense Substances 0.000 claims abstract description 21
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 claims abstract description 19
- 235000006226 Areca catechu Nutrition 0.000 claims abstract description 19
- 239000009286 sanguis draxonis Substances 0.000 claims abstract description 18
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 17
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 17
- 241000131329 Carabidae Species 0.000 claims abstract description 16
- 241000903946 Clematidis Species 0.000 claims abstract description 15
- 241000237636 Pheretima Species 0.000 claims abstract description 15
- 241000628997 Flos Species 0.000 claims abstract description 14
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 238000000034 method Methods 0.000 claims abstract description 6
- 244000080767 Areca catechu Species 0.000 claims abstract 6
- 210000000629 knee joint Anatomy 0.000 claims description 11
- 239000006194 liquid suspension Substances 0.000 claims description 11
- 235000011837 pasties Nutrition 0.000 claims description 9
- 239000000052 vinegar Substances 0.000 claims description 9
- 235000021419 vinegar Nutrition 0.000 claims description 9
- 239000004744 fabric Substances 0.000 claims description 8
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 6
- 229910052802 copper Inorganic materials 0.000 claims description 6
- 239000010949 copper Substances 0.000 claims description 6
- 238000001704 evaporation Methods 0.000 claims description 6
- 230000008020 evaporation Effects 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 230000008901 benefit Effects 0.000 claims description 4
- 241000283690 Bos taurus Species 0.000 claims description 3
- 238000001354 calcination Methods 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 210000000582 semen Anatomy 0.000 claims description 2
- 239000002023 wood Substances 0.000 claims description 2
- RYGMFSIKBFXOCR-AHCXROLUSA-N copper-60 Chemical compound [60Cu] RYGMFSIKBFXOCR-AHCXROLUSA-N 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 70
- 239000008280 blood Substances 0.000 abstract description 68
- 208000002193 Pain Diseases 0.000 abstract description 57
- 230000036407 pain Effects 0.000 abstract description 55
- 230000000694 effects Effects 0.000 abstract description 50
- 210000003205 muscle Anatomy 0.000 abstract description 25
- 230000008961 swelling Effects 0.000 abstract description 22
- 230000001737 promoting effect Effects 0.000 abstract description 20
- 230000017531 blood circulation Effects 0.000 abstract description 17
- 210000002435 tendon Anatomy 0.000 abstract description 12
- 230000002040 relaxant effect Effects 0.000 abstract description 6
- 230000003213 activating effect Effects 0.000 abstract description 3
- 230000029058 respiratory gaseous exchange Effects 0.000 abstract description 2
- 239000003814 drug Substances 0.000 description 26
- 210000004185 liver Anatomy 0.000 description 22
- 206010017076 Fracture Diseases 0.000 description 17
- 208000010392 Bone Fractures Diseases 0.000 description 15
- 210000003734 kidney Anatomy 0.000 description 14
- 231100000614 poison Toxicity 0.000 description 14
- 244000235603 Acacia catechu Species 0.000 description 13
- 238000002560 therapeutic procedure Methods 0.000 description 12
- 208000006820 Arthralgia Diseases 0.000 description 10
- 206010007247 Carbuncle Diseases 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 10
- 208000027418 Wounds and injury Diseases 0.000 description 9
- 230000000202 analgesic effect Effects 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 8
- 210000001624 hip Anatomy 0.000 description 8
- 201000000736 Amenorrhea Diseases 0.000 description 7
- 206010001928 Amenorrhoea Diseases 0.000 description 7
- 231100000540 amenorrhea Toxicity 0.000 description 7
- 201000010099 disease Diseases 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000019634 flavors Nutrition 0.000 description 7
- 238000005469 granulation Methods 0.000 description 7
- 230000003179 granulation Effects 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 208000008035 Back Pain Diseases 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 6
- 208000008930 Low Back Pain Diseases 0.000 description 6
- 206010052428 Wound Diseases 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 230000023597 hemostasis Effects 0.000 description 6
- 241000411851 herbal medicine Species 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- 239000002574 poison Substances 0.000 description 6
- 238000005728 strengthening Methods 0.000 description 6
- 239000003440 toxic substance Substances 0.000 description 6
- 208000033809 Suppuration Diseases 0.000 description 5
- 208000025865 Ulcer Diseases 0.000 description 5
- 210000001015 abdomen Anatomy 0.000 description 5
- 230000001276 controlling effect Effects 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 206010010904 Convulsion Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 206010061363 Skeletal injury Diseases 0.000 description 4
- 206010040943 Skin Ulcer Diseases 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 230000036461 convulsion Effects 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 208000035861 hematochezia Diseases 0.000 description 4
- 201000007227 lymph node tuberculosis Diseases 0.000 description 4
- 244000052769 pathogen Species 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 231100000019 skin ulcer Toxicity 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 206010000077 Abdominal mass Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 208000034656 Contusions Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 206010021118 Hypotonia Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010024453 Ligament sprain Diseases 0.000 description 3
- 206010062575 Muscle contracture Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 208000006111 contracture Diseases 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 208000017561 flaccidity Diseases 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 208000006750 hematuria Diseases 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 2
- 206010020880 Hypertrophy Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 208000005647 Mumps Diseases 0.000 description 2
- 208000007101 Muscle Cramp Diseases 0.000 description 2
- 241000475481 Nebula Species 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 208000006735 Periostitis Diseases 0.000 description 2
- 208000012287 Prolapse Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 208000004680 Rectal Fistula Diseases 0.000 description 2
- 208000010040 Sprains and Strains Diseases 0.000 description 2
- 208000002474 Tinea Diseases 0.000 description 2
- 241000130764 Tinea Species 0.000 description 2
- 206010051373 Wound haemorrhage Diseases 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 206010002156 anal fistula Diseases 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 208000034526 bruise Diseases 0.000 description 2
- 210000000845 cartilage Anatomy 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 230000007850 degeneration Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 210000002683 foot Anatomy 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 230000002607 hemopoietic effect Effects 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 208000010805 mumps infectious disease Diseases 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 201000008482 osteoarthritis Diseases 0.000 description 2
- 230000037324 pain perception Effects 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 230000035922 thirst Effects 0.000 description 2
- 201000004647 tinea pedis Diseases 0.000 description 2
- 230000008467 tissue growth Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- DWNBOPVKNPVNQG-LURJTMIESA-N (2s)-4-hydroxy-2-(propylamino)butanoic acid Chemical compound CCCN[C@H](C(O)=O)CCO DWNBOPVKNPVNQG-LURJTMIESA-N 0.000 description 1
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical compound C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- VAJVDSVGBWFCLW-UHFFFAOYSA-N 3-Phenyl-1-propanol Chemical compound OCCCC1=CC=CC=C1 VAJVDSVGBWFCLW-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 241001517488 Clavus Species 0.000 description 1
- 240000007311 Commiphora myrrha Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 1
- 208000027219 Deficiency disease Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010013908 Dysfunctional uterine bleeding Diseases 0.000 description 1
- 206010013954 Dysphoria Diseases 0.000 description 1
- 206010055690 Foetal death Diseases 0.000 description 1
- 206010017577 Gait disturbance Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010023232 Joint swelling Diseases 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 208000029951 Laryngeal disease Diseases 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241000243684 Lumbricus Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010028347 Muscle twitching Diseases 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 206010031256 Osteomyelitis chronic Diseases 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 240000002834 Paulownia tomentosa Species 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- DYUQAZSOFZSPHD-UHFFFAOYSA-N Phenylpropyl alcohol Natural products CCC(O)C1=CC=CC=C1 DYUQAZSOFZSPHD-UHFFFAOYSA-N 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000018525 Postpartum Hemorrhage Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 1
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241000293871 Salmonella enterica subsp. enterica serovar Typhi Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000008765 Sciatica Diseases 0.000 description 1
- 206010039897 Sedation Diseases 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 208000037114 Symptom Flare Up Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229940118377 Vitamin antagonist Drugs 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 206010053692 Wound complication Diseases 0.000 description 1
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 210000001188 articular cartilage Anatomy 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000002146 bilateral effect Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000003797 carpal joint Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000009519 contusion Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 201000010582 ecthyma Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000001513 elbow Anatomy 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 229940095991 ferrous disulfide Drugs 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000000610 foot bone Anatomy 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- GXMWXESSGGEWEM-UHFFFAOYSA-N isoquercitrin Natural products OCC(O)C1OC(OC2C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)C(O)C1O GXMWXESSGGEWEM-UHFFFAOYSA-N 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- -1 mend stomach Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 210000000236 metacarpal bone Anatomy 0.000 description 1
- 230000029052 metamorphosis Effects 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000003739 neck Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 210000003460 periosteum Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 229910052683 pyrite Inorganic materials 0.000 description 1
- 239000011028 pyrite Substances 0.000 description 1
- NIFIFKQPDTWWGU-UHFFFAOYSA-N pyrite Chemical compound [Fe+2].[S-][S-] NIFIFKQPDTWWGU-UHFFFAOYSA-N 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 1
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000036280 sedation Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 210000002832 shoulder Anatomy 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000003270 steroid hormone Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
- A61K36/126—Drynaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/708—Rheum (rhubarb)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/732—Chaenomeles, e.g. flowering quince
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/739—Sanguisorba (burnet)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Insects & Arthropods (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明提供一种用于接骨和治疗跌打损伤、骨质增生的膏药,它主要由以下质量的原料熬制而成:乳香、没药、儿茶、地榆、大黄、血竭、当归、川芎、自然铜、红花、土鳖、珍珠、杜仲、川断、牛膝、木瓜、透骨草、接骨草、骨碎补、三七、地龙、威灵仙、黄丹,所述膏药具有活血化瘀、消肿止痛、舒筋活络、祛湿除风、快速续筋接骨和缓解疼痛的功效,用于治疗跌打损伤、闷腰岔气、伤筋动骨、瘀血肿痛、骨质增生、腰椎盘突出。本发明还提供上述膏药的制备方法,该方法工艺简单、易于操作。
Description
技术领域
本发明属于中药技术领域,具体的说,本发明涉及一种用于接骨和治疗跌打损伤、骨质增生的膏药及其制备方法。
背景技术
日常生活中,体力工作者、运动员、部队官兵、警察因工作关系需要进行高强度的劳动和训练,普通人也偶尔会进行高强度的肢体活动,容易在腰部、膝、肩、肘、颈、腕关节和踝关节部位发生扭挫筋伤。扭挫伤通常是由肌肉、筋膜、韧带、软骨和关节超负荷运动或用力过猛而引起的,症状表现为红肿瘀血或伴随外皮出血,同时也往往伴随着各种并发炎症。
另一方面,随着现代生活节奏的加快,人们在工作和生活的压力之下,容易忽视健康保养,尤其是对经常处于高温、多湿环境下的人来说,受风寒、风湿侵袭,各种骨科炎症也严重影响正常的生活质量。无论是偶发性的筋骨损伤,还是外感性的骨科炎症,以及骨科术后的愈合期,因常规药物促使生筋长骨速度慢,都需要经过长时间的骨质生长钙化期,且在此期间病患都需要承受剧烈的疼痛、肢体痉挛等痛苦。
数千年来我国在治疗骨伤病方面积累了丰富的经验,临床上通常采用内服中草药或外涂膏药治疗本病,但治疗时间长、费用高、疗效低,病人难以接受。今年来,传统的中医和草医又有很多新的配方,但用这些配方的药物治疗后大多不理想,效果不明显加上昂贵的治疗费用使多数病人望而却步。
发明内容
由鉴于此,本发明确有必要提供一种用于接骨和治疗跌打损伤、骨质增生的膏药及其制备方法,以解决上述问题。
本发明所采用的技术方案是:一种用于接骨和治疗跌打损伤、骨质增生的膏药,它主要由以下质量的原料熬制而成:乳香30 g~60 g、没药30 g~60 g、儿茶15 g~30 g、地榆20 g~40 g、大黄20 g~40 g、血竭20 g~50 g、当归50 g~120 g、川芎20 g~50 g、自然铜50 g~120 g、红花30 g~60 g、土鳖50 g~120 g、珍珠20 g~60 g、杜仲30 g~60 g、川断50 g~100 g、牛膝50 g~120 g、木瓜50 g~120 g、透骨草50 g~120 g、接骨草或接骨木50 g~100 g、骨碎补60 g~100 g、三七50 g~120 g、地龙50 g~100 g、威灵仙30 g~50 g、黄丹60 g~120 g和芝麻油2000 g~4000 g。
基于上述,所述用于接骨和治疗跌打损伤、骨质增生的膏药主要由以下质量的原料熬制而成:乳香40 g~50 g、没药40 g~50 g、儿茶20 g~25 g、地榆25 g~35 g、大黄25g~35 g、血竭30 g~45 g、当归55 g~100 g、川芎30 g~40 g、自然铜60 g~100 g、红花45 g~55 g、土鳖60 g~100 g、珍珠30 g~50 g、杜仲40 g~55 g、川断60 g~90 g、牛膝60 g~100 g、木瓜60 g~90 g、透骨草70 g~100 g、接骨草或接骨木70 g~90 g、骨碎补70 g~90 g、三七70 g~100 g、地龙70 g~90 g、威灵仙40 g~45 g、黄丹80 g~90 g和芝麻油2500 g~3500 g。
本发明还提供一种用于接骨和治疗跌打损伤、骨质增生的膏药,它包括衬布和涂覆在衬布上的膏状物,所述膏状物由以下质量的原料熬制而成:乳香30 g~60 g、没药30 g~60 g、儿茶15 g~30 g、地榆20 g~40 g、大黄20 g~40 g、血竭20 g~50 g、当归50 g~120 g、川芎20 g~50 g、自然铜50 g~120 g、红花30 g~60 g、土鳖50 g~120 g、珍珠20g~60 g、杜仲30 g~60 g、川断50 g~100 g、牛膝50 g~120 g、木瓜50 g~120 g、透骨草50 g~120 g、接骨草或接骨木50 g~100 g、骨碎补60 g~100 g、三七50 g~120 g、地龙50 g~100 g、威灵仙30 g~50 g、黄丹60 g~120 g和芝麻油2000 g~4000 g。
本发明还提供一种用于接骨和治疗跌打损伤、骨质增生的膏药的制备方法,具体制备步骤包括:
(1)按照上述质量的原料,分别称取各原料;
(2)分别将所述乳香、所述没药、所述儿茶、所述血竭、所述珍珠研磨过筛,将所述自然铜烧红用醋煅后研磨过筛;
(3)将所述地榆、大黄、当归、川芎、红花、土鳖、杜仲、川断、牛膝、木瓜、透骨草、接骨草、骨碎补、三七、地龙、威灵仙混合浸泡在水中,经加热煮沸4小时~5小时后进行过滤处理得到过滤液,然后对所述过滤液进行加热浓缩,其中控制经浓缩处理后得到液体悬浮液的体积为300mL;
(4)向所述液体悬浮液中加入芝麻油加热蒸发缩水,其中所述液体悬浮液与所述芝麻油的体积比为1:(2~5),然后向所述蒸发缩水后的液体悬浮液中依次加入黄丹和研磨处理后的所述乳香、所述没药、所述儿茶、所述血竭、所述珍珠、经过煅烧醋煅研磨后的所述自然铜进行搅拌混合,并采用文火熬制成膏状物质,其中,所述膏状物质以滴水成珠、用手捻不粘手为最好,从而制得所述用于接骨和治疗跌打损伤、骨质增生的膏药。
基于上述,所述用于接骨和治疗跌打损伤、骨质增生的膏药的制备方法还包括将所述膏状物质涂覆在衬布上的步骤。
中医理论认为:骨折创伤及跌打损伤、骨质增生必然引起体内经络、血气以及脏腑功能紊乱,从而造成血气俱伤、营卫脏腑不和、经络阻遏、骨髓及骨膜和周围组织及血运破坏,因此,在治疗上应遵循调理气血经络、消肿止痛、活血祛瘀同时兼用补气行血、生血养血,从而达到活血化瘀、促进骨质生长的、生肌、快速续筋接骨和缓解疼痛的目的。
具体地,本发明提供的用于接骨和治疗跌打损伤、骨质增生的膏药配方中,各药物的主要功效分析如下:
接骨木,性味甘、苦、平。功效主治:祛风、利湿、止痛、治风湿筋痛、骨刺疼痛、腰痛、水肿、风痒、瘾疹、产后血晕、跌打肿痛、创伤出血。
接骨草,味苦,性平。功能主治:活血散瘀,消肿止咳,治疗跌打扭伤,痄腮,闭经,咳嗽。据《滇南本草》载:“行十二经络,治筋骨痰火、 疼痛、手足麻木不仁。散瘰手足痰核,治跌打损伤,接骨。”现代医学研究证实,接骨草所含的槲皮素、槲皮甙、异槲皮甙等对金黄色葡萄球杆菌、伤寒杆菌具有较强的抑制作用,所含的金丝桃甙具明显的抗炎作用。
骨碎补,味苦,性温;归肾、肝经。功效主治:补肾、活血、止痛止血、治肾虚欠泻、腰痛、风湿腰痛、齿痛、耳鸣、跌打闪挫、骨折骨伤、阑尾炎、斑秃、鸡眼。据《本草正》载:“疗骨中邪毒,风热疼痛,或外感风湿,以致两足痿弱疼痛。”现代医学研究证实,骨碎补对骨损伤愈合有促进作用,能刺激骨关节软骨细胞代偿性增生,并能改善由于力学应力线改变造成关节软骨的退行性变,降低骨关节病变率。
透骨草,味辛、苦,性温,有小毒;归肝、肾经。功效主治:祛风、除湿、舒筋、活血、止痛、治风湿痹痛、筋骨挛缩、寒湿脚气、疮癣肿毒。据《东北常用中草药手册》载:“舒筋活血,祛风止痛。治腰腿疼痛,大骨节病关节痛,筋骨麻木,扭挫伤,闪腰岔气。”
牛膝,味甘、微苦,性平;归肝、肾经。功效主治:活血散瘀、祛湿利尿、清热解毒、治淋病、尿血、妇女经闭、风湿关节炎疼痛、脚气水肿、痢疾、疟疾、白喉、痈肿、跌打损伤、腰膝骨痛、强筋骨、四肢拘筋、痿痹。据《中药志》载:“破血下降,治打扑刀伤,有缓和疼痛之效。”现代医学研究证实,牛膝所含的昆虫变态甾体激素和杯苋甾桐对蛋白质具体同化作用。
大黄,性味苦、寒,归脾、胃、大肠、肝、心包经。功效主治:泻热毒、破积滞、行淤血、治实热便秘、谵语发狂、食积痞满、痢疾初起里急后重、瘀停经闭、癓瘕积聚。
红花,性味辛、温,归心、肝经。功效主治:活血通络、去瘀止痛、治闭经、癓瘕、难产、死胎、产后恶露不行、瘀血作痛、痈肿、跌打损伤。据《开宝本草》记载:“主产后血运口噤,腹内恶血不尽、绞痛,胎死腹中,并酒煮服。亦主蛊毒下血”;据《纲目》记载:“活血,润燥,止痛,散肿,通经”。
乳香,味辛、苦,性微温,入心、肝、脾经。其功效主治:调气活血、定痛、追毒、治气血凝滞、心腹疼痛、痈疮肿痛、跌打损伤、痛经、产后瘀血刺痛。据《纲目》载:“消痈疽诸毒,托里护心,活血定痛,伸筋”。现代医学研究证实,乳香挥发油有镇痛作用,能促进多核白血球增加,从而吞噬死亡的血球及细胞,改善新陈代谢,有消炎防腐作用。
地榆,性微寒、味苦。功效主治:凉血止血、解毒敛疮、主治便血、痔疮出血、血痢、崩漏、水火烫伤、痈肿疮毒。据《本草选旨》记载:地榆,以之止血,取上截炒用。以之行血、取下截生用。以之敛血,则同归、芍。以之清热,则同归、连。以之治湿,则同归、芩。以之治血中之痛,则同归、萸。以之温经而益血,则同归、姜。大抵酸敛寒收之剂,得补则守,得寒则凝,得温暖而益血归经,在善用者自得之而已。”现代医学研究证明:地榆具有止血凉血、清热解毒 、收敛止泻及抑制多种致病微生物和肿瘤的作用 ,可治疗吐血、血痢、烧灼伤、湿疹、上消化道出血、溃疡病大出血、便血、崩漏、结核性脓疡及慢性骨髓炎等疾病。
威灵仙,味辛,咸,性温,有毒;入肺、肾二经。功效主治:祛风除湿、通络止痛、主治风湿痹痛、肢体麻木、筋脉拘挛、屈伸不利、骨鲠咽喉。据《开宝本草》载:“主诸风,宣通五藏,去腹内冷滞,心隔痰水久积,症瘕痃癣气块,膀胱宿脓恶水,腰膝冷痛及疗折伤。”现代医学研究证实,威灵仙具有镇痛作用,能明显增强葡萄糖同化效果。
木瓜功效主治:平肝舒筋、和胃化湿、主治湿痹拘挛、腰膝关节酸重疼痛、吐泻转筋、脚气水肿。
当归,性温,味甘、辛;归肝、心、脾经。主治:补血、活血、调经止痛、润肠通便、纸质血虚萎黄眩晕心悸、月经不调、经闭痛经、虚寒腹痛、肠燥便秘、风湿痹痛、跌打损伤、痈疽疮疡。据《本草正》载:“其味甘而重,故专能补血,其气轻而辛,故又能行血,能养血,补气生精,安五脏,强形体,益神志,凡有形虚功效。”
川芎,性味辛、温,入肝、胆经。功能主治:活血行气、祛风止痛、主治月经不调、闭经痛经、症瘕腹痛、胸肋刺痛、跌打损伤、头痛、风湿痹痛。据《日华子本草》记载:“治一切风,一切气,一切劳损,一切血,补五劳,壮筋骨,调众脉,破症结宿血,养新血,长肉,鼻洪,吐血及溺血,痔瘘,脑痈发背,瘰疬瘿赘,疮疥,及排脓消瘀血”。
三七,性温、味甘、微苦、无毒,归肝、胃、心、肺、大肠经。其功效主治:活血去瘀、止血、消肿止痛、主治衄血、吐血、咯血、便血、功能性子宫出血、产后血瘀腹痛、跌打损伤。据《本草纲目》记载:“三七……止血,散血,定痛”。据《玉揪药解》记载:“和营止血,通脉行瘀,行瘀血而敛新血”。现代医学研究证实,三七具有止血、抗血栓、促进造血、心血管系统保健、抗炎、保肝、抗肿瘤、镇痛的药理功效。
杜仲,味甘、微辛,性温;入肝经、肾经。功效主治:补肝肾、强筋骨、安胎、主治肾虚腰痛、筋骨无力、妊娠漏血、胎动不安、高血压。据《备急千金要方》载:“功能祛风湿,止痹痛,益肝肾,补气血……感受风寒湿邪,腰膝冷痛,肢节屈伸不利,或麻痹不仁,畏寒喜温。”现代医学研究证实,杜仲对神经中枢有镇静作用,能增强细胞的免疫功能,促进皮质醇分泌和血浆中CAMP和CGMP代谢。
没药,味苦、辛,性平;入肝、脾、心、肾经。没药为橄榄科植物没药树及同属植物树干皮部渗出的油胶树脂,功效主治:散血去瘀、消肿定痛、主治跌打损伤、金疮、筋骨心腹诸痛、症瘕、经闭、痈疽肿痛、痔漏、目障。现代医学研究证实,没药可调节甲状腺,具有强力消炎、杀菌、止痛以及对抗病毒的效果。
血竭,性味甘、咸、平,归心、肝经,功效主治:散瘀定痛、止血生肌、主治跌打损伤、内伤瘀痛、伤口出血不止、瘰疬、臁疮溃久不合。据《本经逢原》:“治伤折打损一切疼痛,血气搅刺,内伤血聚,并宜酒服。乳香、没药虽主血病而兼入气分,此则专于肝经血分也。但性最急却能引脓,不宜多服。其助阳药中同乳香、没药用之者,取以调和血气而无留滞壅毒之患。”
川断,味苦,辛,性微温;归肝、肾经。功效主治:善补肝肾、强筋骨、壮腰脚、行血脉安胎的功效、崩漏下血、胎动欲坠、腰痛脚弱、遗精及跌打损伤、金疮痈疡等症。据《证治准绳》载:“甘温助阳,辛以散瘀,兼有补益肝肾,强健壮骨,通利血脉之功。”现代医学研究证实,川断含有多种生物碱和微量元素钛,有抗维生素E 缺乏症的作用,对痈疡有排脓、止血、镇痛、促进组织再生的作用。
地龙,又名蚯蚓,功效主治:清热平肝、止喘通络、治高热狂躁、惊风抽搐、风热头痛、目赤、中风半身不遂、喘息、喉痹、关节疼痛、小便不通、瘰疬、痄腮、疮疡。
儿茶,性味苦、涩,微寒,归肺、心经。功效主治:清热化痰、止血、消食生肌、定痛、治痰热咳嗽、消渴、吐血、血衄、尿血、血痢、血崩、小儿消化不良、牙疳、口疮、喉痹、湿疮。据《本草纲目》记载:“清上膈热,化痰生津。涂金疮、一切诸疮,生肌定痛,止血收湿。”据《本经逢原》记载:“儿茶,一名乌爹泥,性涩收敛,止血收湿,为金疮止痛生肌之要药。”
土鳖,味咸,性寒,小毒;入肝经。功效主治:通瘀破积、通络、理伤、癓瘕积聚、血滞经闭、产后淤血腹痛、跌打损伤。据《分类草药性》载“治跌打损伤,风湿筋骨痛,消肿,吹喉症。”现代医学研究证实,土鳖至少含有17种氨基酸、28种微量元素,以及多种生物碱,对恶性肿瘤有改善症状的作用,可用于调节血压、血脂、溶栓,此外还有消炎、解毒、镇静等作用,与其他中药配伍对腰痛等顽症具有很高的治疗效果。
珍珠,功效主治:镇心安神、养阴熄风、清热坠痰、去翳明目、解毒生肌、治惊悸、怔忡、癫痫惊风抽搐、烦热消渴、喉痹、口疳、目生翳障、疮口久不收口。《中华人民共和国药典》及《中药大辞典》均指明:珍珠具有安神定惊、明目去翳、解毒生肌等功效,现代研究还表明珍珠在提高人体免疫力、延缓衰老、祛斑美白、补充钙质等方面都具有独特的作用。现代检测表明珍珠的无机成分主要是碳酸钙、碳酸镁;珍珠中的有机物含有门冬氨酸、苏氨酸、丝氨酸、谷氨酸、甘氨酸、丙氨酸、胱氨酸、缬氨酸、蛋氨酸、异亮氨酸、亮氨酸、酪氨酸、苯丙氨酸、组氨酸、精氨酸、脯氨酸等17种氨基酸。另外,还含有30多种微量元素、牛磺酸、丰富的维生素、肽类。
自然铜,为硫化物类矿物黄铁矿族黄铁矿,主要成分为二硫化铁。性味辛、平。功效主治:散瘀止痛、接骨续筋、治跌打损伤、筋断骨折、血瘀疼痛、积聚、瘿瘤、疮疡、烫伤。据《本草衍义补遗》记载:“自然铜,世以为接骨之药,然此等方尽多。大抵骨折在补气、补血、补胃,而铜非煅不可用,若新出火者,其火毒、金毒相扇,挟热毒香药,虽有接骨之功,燥散之祸,甚于刀剑,戒之。”据《本草经疏》记载:“自然铜乃入血行血,续筋接骨之药也。凡折伤则血瘀而作痛,辛能散瘀滞之血,破积聚之气,则痛止而伤自和也。”其中,自然铜以醋自然铜治疗效果较好。
因此,本发明提供的用于接骨和治疗跌打损伤、骨质增生的膏药中所述诸药经配伍和用,具有活血化瘀、消肿止痛、舒筋活络、祛湿除风、快速续筋接骨和缓解疼痛的功效,用于治疗跌打损伤、闷腰岔气、伤筋动骨、瘀血肿痛、骨质增生、腰椎盘突出,且制备工艺简单。
具体实施方式
下面通过具体实施方式,对本发明的技术方案做进一步的详细描述。
实施例1
本实施例提供一种用于接骨和治疗跌打损伤、骨质增生的膏药,它主要由下述质量的药物原料熬制而成:乳香30 g、没药30 g、儿茶15 g、地榆20 g、大黄20 g、血竭20 g、当归50 g、川芎20 g、自然铜50 g、红花30 g、土鳖50 g、珍珠20 g、杜仲30 g、川断50 g、牛膝50 g、木瓜50 g、透骨草50 g、接骨草50 g、骨碎补60 g、三七50 g、地龙50 g、威灵仙30 g、黄丹60 g、芝麻油3000 g。其中,所述自然铜是经过炮制后所得的醋自然铜。
本发明还提供一种用于接骨和治疗跌打损伤、骨质增生的膏药的制备方法,具体制备步骤包括:
(1)按照上述质量的原料分别称取乳香、没药、儿茶、地榆、大黄、血竭、当归、川芎、自然铜、红花、土鳖、珍珠、杜仲、川断、牛膝、木瓜、透骨草、接骨草、骨碎补、三七、地龙、威灵仙、黄丹。
(2)分别将所述乳香、所述没药、所述儿茶、所述血竭、所述珍珠研磨过筛,将所述自然铜烧红用醋煅后研磨过筛;其中,所述筛网的目数为100目。
(3)将所述地榆、大黄、当归、川芎、红花、土鳖、杜仲、川断、牛膝、木瓜、透骨草、接骨草、骨碎补、三七、地龙、威灵仙混合浸泡在水中,经加热煮沸4小时后进行过滤处理得到过滤液,然后对所述过滤液进行加热浓缩,其中控制经浓缩处理后得到液体悬浮液的体积为300mL左右。
(4)向所述液体悬浮液中加入所述芝麻油,并加热蒸发缩水,然后向所述蒸发缩水后的液体悬浮液中加入黄丹和研磨处理后的所述乳香、所述没药、所述儿茶、所述血竭、所述珍珠和经过煅烧醋煅研磨后的所述自然铜,搅拌混合并采用文火熬制成膏状物质,其中,所述膏状物质以滴水成珠、用手捻不粘手为最好。
(5)将所述膏状物质涂覆在衬布上制得所述用于接骨和治疗跌打损伤、骨质增生的膏药。
用法用量:确定骨伤或骨科炎症所在部位后,清洁患处部位皮肤,取本发明提供的膏药贴于炎症所在部位,每贴贴敷有效期为5天至7天,通常6~9贴为一个疗程,需注意的是:对外伤患者及孕妇禁用,对本产品有皮肤过敏者应慎用。
为验证其疗效,现将临床资料疗效观察结果报告如下:以50例腰椎间盘突出或骨质增生患者为治疗对象进行疗效跟踪,年龄分布为35~65岁,治疗过程贴敷八贴为一疗程。
治疗过程中,50名患者经贴敷所述用于接骨和治疗跌打损伤、骨质增生的膏药两贴后,肿胀、疼痛减轻,贴敷用八张膏药后,50位患者肿胀现象完全消退、再无疼痛感,达到治愈效果。
典型病例:
许某,男,59岁,河南省郑州市人。患有腰椎间盘突出并伴有骨质增生、坐骨神经痛八年,且近一年来腰椎间盘疼痛越来越重,基本不能劳动、行走困难、遇到寒冷天气疼痛症状加重。患者经多家医院治疗,其疼痛症状时轻时重,表情非常痛苦。经贴敷用本发明提供的外贴膏药两贴共十天后,所述疼痛症状有所好转,继续贴敷本发明所述的膏药,前后经贴敷八张后上述症状基本痊愈,且追访至今未复发,患者本人对治疗效果非常满意。
王某,男,48岁,河南省郑州市人。患有骨质增生两年,且近一年来疼痛加剧,不能久坐和长时间劳动。患者先后经输液、针灸等手段治疗后,虽然疼痛有所减轻,但依然不见痊愈。经贴敷用本发明提供的外贴膏药三贴后,所述疼痛症状完全消失,继续贴敷本发明所述的膏药,前后经贴敷六张后,经X光检查,骨质增生部位已经软化消退,且追访至今未复发,患者本人对治疗效果非常满意。
实施例2
本实施例提供一种用于接骨和治疗跌打损伤、骨质增生的膏药,它主要由下述质量的药物原料熬制而成:乳香50 g、没药50 g、儿茶25 g、地榆35 g、大黄35 g、血竭45 g、当归100 g、川芎40 g、自然铜100 g、红花55 g、土鳖100 g、珍珠50 g、杜仲55 g、川断90 g、牛膝100 g、木瓜90 g、透骨草100 g、接骨草90 g、骨碎补90 g、三七100 g、地龙90 g、威灵仙45 g、黄丹90 g、芝麻油3500 g。其中,所述自然铜是经过炮制后所得的醋自然铜。
本发明还提供一种用于接骨和治疗跌打损伤、骨质增生的膏药的制备方法,具体制备步骤同实施例1中的制备步骤。
为验证其疗效,现将临床资料疗效观察结果报告如下:以30例关节炎或关节疼痛患者为治疗对象进行疗效跟踪,年龄分布为35~70岁,治疗过程贴敷九贴一疗程。
治疗过程中,30名患者经贴敷所述用于接骨和治疗跌打损伤、骨质增生的膏药三贴后,肿胀、疼痛减轻,基本能够行走,贴敷用八个疗程后29位患者关节再无肿胀现象,疼痛完全消退、再无疼痛感,达到治愈效果。
典型案例
李某,男,56岁,在交通局工作,右侧膝关节肿胀,伸曲不便且行走时疼痛难忍,经医院诊断确诊为膝关节退行性病变、膝关节骨质增生并伴有关节腔轻度积液和骨膜炎。该患者在医院先后经过输液、打封闭针、做小针刀等治疗手段均不见好转。最后经贴敷本发明所提供的所述用于接骨和治疗跌打损伤、骨质增生的膏药并伴随热敷疗法,治疗一段时间后即贴敷完3贴所述膏药后,患者基本能够正常行走,前后共贴敷九贴后,患者的膝关节再无肿胀现象,疼痛感觉完全消失,达到了治愈的效果且追访至今未复发,患者本人对治疗效果非常满意。
高某,男,39岁,因长期高劳动强度及营养不均衡,导致双侧膝关节疼痛难忍并伴随有轻度肿胀。该患者服用西药一段时间后,虽然缓解了关节部位的疼痛症状,但依然存在时断时续的疼痛现象,未完全治愈,且由于长时间服用西药导致食欲显著下降。最后经贴敷本发明所提供的所述用于接骨和治疗跌打损伤、骨质增生的膏药,贴敷完2贴所述膏药后,患者基本能够正常行走,且食欲增强。该患者前后共贴敷六贴后,患者的膝关节再无肿胀现象,疼痛感觉完全消失,达到了治愈的效果且追访至今未复发,患者本人对治疗效果非常满意。
实施例3
本实施例提供一种用于接骨和治疗跌打损伤、骨质增生的膏药,它主要由下述质量的药物原料熬制而成::乳香60 g、没药60 g、儿茶30 g、地榆40 g、大黄40 g、血竭50 g、当归120 g、川芎50 g、自然铜120 g、红花60 g、土鳖120 g、珍珠60 g、杜仲60 g、川断100 g、牛膝120 g、木瓜120 g、透骨草120 g、接骨木100 g、骨碎补100 g、三七120 g、地龙100 g、威灵仙50 g、黄丹120 g、芝麻油2800 g。
本发明还提供一种用于接骨和治疗跌打损伤、骨质增生的膏药的制备方法,具体制备步骤与实施例1的制备步骤相同。
为验证其疗效,现将临床资料疗效观察结果报告如下:以22例跌倒骨折患者为治疗对象进行疗效跟踪,年龄分布为18~70岁,治疗过程贴敷六贴一疗程。
治疗过程中,22名患者经贴敷所述用于接骨和治疗跌打损伤、骨质增生的膏药五天后,肿胀消失、疼痛减轻,贴敷六个疗程后22位患者骨折部位经X光检测基本痊愈,达到治愈效果。
典型案例
贾某、男、65岁、由于经常喝酒不慎跌倒致使左脚骨掌骨折、疼痛难忍,经医院X光检查后诊断为横断骨折,医生建议手术,患者因经济原因,在进行骨折部位复位后进行保守治疗,同时在骨折部位贴敷本发明提供的所述用于接骨和治疗跌打损伤、骨质增生的膏药,贴敷五天后,肿胀现象消退,前后共贴敷六贴后,经X光检查骨折部位基本痊愈,且随访至今未骨折部位未出现疼痛、肿胀现象。
施某,男,22岁,由于在体育赛事中不小心造成小腿胫骨轻度骨折,疼痛难忍,骨折部位伴随有肿胀现象。因学业需要,在医院进行骨折部位复位后,在学校进行保守治疗,即在骨折部位贴敷本发明提供的所述用于接骨和治疗跌打损伤、骨质增生的膏药,贴敷五天后,肿胀现象消退、疼痛感减轻。该患者前后共贴敷六贴后,经X光检查骨折部位基本痊愈,且随访至今未骨折部位未出现疼痛、肿胀现象。
最后应当说明的是:以上实施例仅用以说明本发明的技术方案而非对其限制;尽管参照较佳实施例对本发明进行了详细的说明,所属领域的普通技术人员应当理解:依然可以对本发明的具体实施方式进行修改或者对部分技术特征进行等同替换;而不脱离本发明技术方案的精神,其均应涵盖在本发明请求保护的技术方案范围当中。
Claims (5)
1.一种用于接骨和治疗跌打损伤、骨质增生的膏药,其特征在于,它主要由以下质量的原料熬制而成:乳香30 g~60 g、没药30 g~60 g、儿茶15 g~30 g、地榆20 g~40 g、大黄20 g~40 g、血竭20 g~50 g、当归50 g~120 g、川芎20 g~50 g、自然铜50 g~120 g、红花30 g~60 g、土鳖50 g~120 g、珍珠20 g~60 g、杜仲30 g~60 g、川断50 g~100 g、牛膝50 g~120 g、木瓜50 g~120 g、透骨草50 g~120 g、接骨草或接骨木50 g~100 g、骨碎补60 g~100 g、三七50 g~120 g、地龙50 g~100 g、威灵仙30 g~50 g、黄丹60 g~120 g和芝麻油2000 g~4000 g。
2.根据权利要求1所述的用于接骨和治疗跌打损伤、骨质增生的膏药,其特征在于,它主要由以下质量的原料熬制而成:乳香40 g~50 g、没药40 g~50 g、儿茶20 g~25 g、地榆25 g~35 g、大黄25 g~35 g、血竭30 g~45 g、当归55 g~100 g、川芎30 g~40 g、自然铜60 g~100 g、红花45 g~55 g、土鳖60 g~100 g、珍珠30 g~50 g、杜仲40 g~55 g、川断60 g~90 g、牛膝60 g~100 g、木瓜60 g~90 g、透骨草70 g~100 g、接骨草或接骨木70 g~90 g、骨碎补70 g~90 g、三七70 g~100 g、地龙70 g~90 g、威灵仙40 g~45g、黄丹80 g~90 g和芝麻油2500 g~3500 g。
3.一种用于接骨和治疗跌打损伤、骨质增生的膏药,包括衬布和涂覆在衬布上的膏状物,其特征在于,所述膏状物由以下质量的原料熬制而成:乳香30 g~60 g、没药30 g~60g、儿茶15 g~30 g、地榆20 g~40 g、大黄20 g~40 g、血竭20 g~50 g、当归50 g~120g、川芎20 g~50 g、自然铜50 g~120 g、红花30 g~60 g、土鳖50 g~120 g、珍珠20 g~60 g、杜仲30 g~60 g、川断50 g~100 g、牛膝50 g~120 g、木瓜50 g~120 g、透骨草50g~120 g、接骨草或接骨木50 g~100 g、骨碎补60 g~100 g、三七50 g~120 g、地龙50 g~100 g、威灵仙30 g~50 g、黄丹60 g~120 g和芝麻油2000 g~4000 g。
4.一种用于接骨和治疗跌打损伤、骨质增生的膏药的制备方法,具体制备步骤包括:
(1)按照权利要求1或2或3所述的质量分别称各原料;
(2)分别将所述乳香、所述没药、所述儿茶、所述血竭、所述珍珠研磨过筛,将所述自然铜烧红用醋煅后研磨过筛;
(3)将所述地榆、大黄、当归、川芎、红花、土鳖、杜仲、川断、牛膝、木瓜、透骨草、接骨草、骨碎补、三七、地龙、威灵仙混合浸泡在水中,经加热煮沸4小时~5小时后进行过滤处理得到过滤液,然后对所述过滤液进行加热浓缩,其中控制经浓缩处理后得到液体悬浮液的体积为300mL左右;
(4)向所述液体悬浮液中加入芝麻油加热蒸发缩水,其中所述液体悬浮液与所述芝麻油的体积比为1:(2~5),然后向所述蒸发缩水后的液体悬浮液中依次加入黄丹和研磨处理后的所述乳香、所述没药、所述儿茶、所述血竭、所述珍珠、经过煅烧醋煅研磨后的所述自然铜进行搅拌混合,并采用文火熬制成膏状物质,其中,所述膏状物质以滴水成珠、用手捻不粘手为最好,从而制得所述用于接骨和治疗跌打损伤、骨质增生的膏药。
5.根据权利要求4所述的用于接骨和治疗跌打损伤、骨质增生的膏药的制备方法,其特征在于,它还包括将所述膏状物质涂覆在衬布上的步骤。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610603729.7A CN106109798A (zh) | 2016-07-28 | 2016-07-28 | 用于接骨和治疗跌打损伤、骨质增生的膏药及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610603729.7A CN106109798A (zh) | 2016-07-28 | 2016-07-28 | 用于接骨和治疗跌打损伤、骨质增生的膏药及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106109798A true CN106109798A (zh) | 2016-11-16 |
Family
ID=57290062
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610603729.7A Pending CN106109798A (zh) | 2016-07-28 | 2016-07-28 | 用于接骨和治疗跌打损伤、骨质增生的膏药及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106109798A (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107213347A (zh) * | 2017-07-01 | 2017-09-29 | 河南中医药大学 | 一种治疗骨折的骨科接骨膏药及其制备方法 |
CN108635484A (zh) * | 2018-06-07 | 2018-10-12 | 张�杰 | 一种治疗骨质增生、膝关节滑膜炎的膏药及其制备方法 |
CN112546145A (zh) * | 2020-11-19 | 2021-03-26 | 湖南兰嗅生物科技有限公司 | 一种化刺膏及制作方法 |
CN112675246A (zh) * | 2020-12-31 | 2021-04-20 | 高四宽 | 一种治疗骨伤疾病的膏药及制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1191741A (zh) * | 1998-01-23 | 1998-09-02 | 李景茂 | 一种跌打扭伤膏药及其制备方法 |
CN105125795A (zh) * | 2015-09-08 | 2015-12-09 | 刘伟 | 一种治疗跌打损伤接骨续筋的膏药及其制备方法 |
CN105362711A (zh) * | 2015-11-30 | 2016-03-02 | 王福运 | 一种治疗骨伤疼痛的膏药及其制备方法 |
-
2016
- 2016-07-28 CN CN201610603729.7A patent/CN106109798A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1191741A (zh) * | 1998-01-23 | 1998-09-02 | 李景茂 | 一种跌打扭伤膏药及其制备方法 |
CN105125795A (zh) * | 2015-09-08 | 2015-12-09 | 刘伟 | 一种治疗跌打损伤接骨续筋的膏药及其制备方法 |
CN105362711A (zh) * | 2015-11-30 | 2016-03-02 | 王福运 | 一种治疗骨伤疼痛的膏药及其制备方法 |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107213347A (zh) * | 2017-07-01 | 2017-09-29 | 河南中医药大学 | 一种治疗骨折的骨科接骨膏药及其制备方法 |
CN108635484A (zh) * | 2018-06-07 | 2018-10-12 | 张�杰 | 一种治疗骨质增生、膝关节滑膜炎的膏药及其制备方法 |
CN112546145A (zh) * | 2020-11-19 | 2021-03-26 | 湖南兰嗅生物科技有限公司 | 一种化刺膏及制作方法 |
CN112675246A (zh) * | 2020-12-31 | 2021-04-20 | 高四宽 | 一种治疗骨伤疾病的膏药及制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102813860B (zh) | 一种治疗风湿骨病膏药 | |
CN101766775A (zh) | 一种治疗腰椎间盘突出、骨质增生的药物 | |
CN104644943A (zh) | 中药组合物、含该组合物的药灸及制备方法 | |
CN105833193A (zh) | 一种治疗风湿骨病膏药 | |
CN105616824A (zh) | 一种接骨续筋膏药及其制备方法 | |
CN106109798A (zh) | 用于接骨和治疗跌打损伤、骨质增生的膏药及其制备方法 | |
CN104815295A (zh) | 一种治疗颈椎病的中药制剂 | |
CN107095982A (zh) | 一种熥敷药剂及其制备方法 | |
CN102895365B (zh) | 一种治疗骨损伤及骨科炎症的外用药膏 | |
CN104306620A (zh) | 一种治疗骨折的外敷中药及其制备方法 | |
CN104922622B (zh) | 一种治疗颈、肩、腰、膝酸胀肿痛的膏药贴及其制备方法 | |
CN103550345B (zh) | 一种治疗风湿疼痛的药酒 | |
CN102626505A (zh) | 基于中草药的按摩膏及其制备方法 | |
CN106309954A (zh) | 一种治疗骨病的膏药 | |
CN105853898A (zh) | 一种用于膝关节康复护理的中药熏洗粉剂及制备方法 | |
CN106215051A (zh) | 一种治疗周围神经损伤的中西复方药物及制备方法 | |
CN107243069A (zh) | 一种治疗颈椎病及腰椎病的外用药物及制备方法 | |
CN104306602A (zh) | 一种天然养骨膏 | |
CN104474372B (zh) | 一种用于骨折术后康复医疗的药丸及制备方法 | |
CN104127620B (zh) | 一种治疗股骨头坏死的中药制剂 | |
CN102935156A (zh) | 一种治疗骨质增生症的丸剂 | |
CN106924673A (zh) | 一种治疗骨质增生的中药组合物及其药剂制备方法 | |
CN106798857A (zh) | 一种治疗骨肿瘤的药物及其制备方法 | |
CN101637535B (zh) | 一种治疗骨质增生的药物及其制备方法 | |
CN104689183A (zh) | 具有消肿散瘀功效的药酒及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161116 |
|
RJ01 | Rejection of invention patent application after publication |